Table 1.
Patient demographics and tumor characteristics
| Characteristic | Percent of assessable patients (no.) |
|---|---|
| Gender | |
| Men | 61 (97) |
| Women | 39 (62) |
| Age (years) | |
| <40 | 19.4 (31) |
| 40–49 | 15.7 (25) |
| 50–59 | 30.2 (48) |
| ≥60 | 34.6 (55) |
| Race | |
| White | 94.3 (150) |
| Other | 5.7 (9) |
| Symptom duration (months) | |
| <2 | 52.2 (83) |
| 2–4 | 22.6 (36) |
| ≥4 | 25.2 (40) |
| Neurological class | |
| 1 Work | 28.3 (45) |
| 2 Home | 66.7 (106) |
| 3 Hospital | 5.0 (8) |
| Karnofsky Performance Status | |
| <70 | 20.8 (33) |
| 70–80 | 55.3 (88) |
| 90–100 | 23.9 (38) |
| Tumor size (cm) | |
| <5.0 | 54.1 (86) |
| ≥5.0 | 45.9 (73) |
| Tumor pathology | |
| GBM | 71.7 (114) |
| AA | 28.3 (45) |
| Tumor location | |
| Frontal | 31.4 (50) |
| Parietal | 16.4 (26) |
| Temporal | 30.8 (49) |
| Occipital | 1.9 (3) |
| Other | 19.5 (31) |
GBM glioblastoma, AA anaplastic astrocytoma